Generex Biotechnology News

21,50 $ +59,26% +8,00 $
In Euro: 19,157 € | 02.11.18 20:59:42 Uhr Nasdaq OTC Other | Mehr Kurse »
WKN: 922012
ISIN: US3714851033
US-Symbol: GNBT
Typ: Aktie

Generex Biotechnology News

  
Mi Generex Addresses the Opioid Crisis; Provides Proven, Non-​Opioid Pain Management Solutions Businesswire
05.11.18 Generex Announces REVISED Record & Payment Dates for 20:1 Stock Dividend Businesswire
02.11.18 Generex Biotechnology Finalizes Acquisition of Remaining Veneto Operating Assets Businesswire
31.10.18 Generex Biotechnology Announces Record & Payment Dates for 20:1 Stock Dividend Businesswire
29.10.18 Generex Biotechnology Announces IND Filing for a Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (Keytruda®) for the Treatment of Triple-​Negative Breast Cancer Businesswire
22.10.18 Generex Confirms & Clarifies 20:1 Common Stock Dividend Businesswire
17.10.18 Generex Announces Launch of NuGenerex Distribution Solutions Businesswire
12.10.18 Generex Announces Anthony S. Crisci, Esq., CPA as General Manager, Chief Compliance Officer and Corporate Counsel of its New, Wholly-​Owned Subsidiary, NuGenerex Distribution Solutions Businesswire
10.10.18 Generex Announces Stock Dividend Businesswire
09.10.18 Generex Announces Closing of First Tranche Acquisition of Operating Assets Businesswire
05.10.18 Generex Biotechnology Provides Update on AE37 Immuno-​Therapeutic Clinical Development Program Businesswire
26.09.18 Generex Launches NuGenerex Medical Marketing Businesswire
20.09.18 Generex Subsidiary Hema Diagnostic Systems, LLC dba NuGenerex Diagnostics Announces Filing of a European CE Marking Application Businesswire
27.08.18 Generex Biotechnology to Present Overview of Immuno-​Oncology Development Program at Summit in Boston, MA Businesswire
25.01.17 Yutaka Niihara, MD, MPH, CEO of Emmaus, Appointed Executive Chairman of Generex Biotechnology Corporation PR Newswire
24.01.17 Emmaus Life Sciences, Inc. Enters into Collaborative Agreement with Generex Biotechnology Corporation PR Newswire
15.10.15 Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine PR Newswire
13.10.15 Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd. PR Newswire
06.10.15 Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd. PR Newswire
01.10.15 Generex Announces Issuance of Buccal Cannabis White Paper PR Newswire
30.09.15 Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems PR Newswire
08.09.15 Generex Announces Commencement of Buccal Leuprolide R&D Work PR Newswire
02.09.15 Generex Announces Formalization of Buccal Cannabis Co-​Development Plan PR Newswire
27.08.15 Generex Announces Issuance of Buccal Insulin White Paper PR Newswire
25.08.15 Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project PR Newswire
06.08.14 Generex Announces Publication of AE37 Prostate Cancer Vaccine Study PR Newswire
17.06.14 Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation PR Newswire
12.06.14 Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial PR Newswire
10.06.14 Generex / Antigen Express to Participate in 2014 BIO International Convention PR Newswire
20.05.14 Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO PR Newswire
30.04.14 Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting PR Newswire
25.04.14 Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting PR Newswire
27.03.14 Generex Announces $2,075,000 Capital Investment PR Newswire
26.03.14 Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium PR Newswire
05.03.14 Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza PR Newswire
27.02.14 Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients PR Newswire
12.02.14 Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial PR Newswire
04.02.14 Generex/Antigen Express "Stock News Now" Interview Available Online PR Newswire
13.01.14 Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial PR Newswire
09.01.14 Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference PR Newswire
06.01.14 Generex/Antigen Express Announce Database Lock of AE37 Breast Cancer Vaccine Trial PR Newswire
18.11.13 Antigen Express AE37 Breast Cancer Vaccine Update PR Newswire
27.09.13 Generex Provides Update on Generex Oral-lyn™ Conference Call PR Newswire
20.08.13 Generex Announces Publication of Follow-up Studies from Phase I Trial of Novel Immunotherapeutic in Prostate Cancer Patients PR Newswire
13.08.13 Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy PR Newswire
12.08.13 Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board PR Newswire
23.07.13 Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board PR Newswire
12.07.13 Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board PR Newswire
10.07.13 Generex Oral-lyn™ Results in More Rapid Reductions of HbA1c in Shreya's Phase III Study of Type 2 Diabetes in India PR Newswire
08.07.13 Generex Announces Conference Call with Members of Generex Oral-lyn™ and Diabetes Program Team PR Newswire

Newssuche

  

Videos

  
15:26 Uhr
DAX, Dow, MDAX, Nasdaq: Darauf müssen Sie jetzt achten